Toroso Investments LLC Purchases 1,343 Shares of Cardinal Health, Inc. (NYSE:CAH)

Toroso Investments LLC increased its position in shares of Cardinal Health, Inc. (NYSE:CAH) by 11.9% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 12,611 shares of the company’s stock after acquiring an additional 1,343 shares during the period. Toroso Investments LLC’s holdings in Cardinal Health were worth $952,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Mitsubishi UFJ Trust & Banking Corp increased its holdings in shares of Cardinal Health by 4.1% in the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 187,535 shares of the company’s stock worth $14,159,000 after buying an additional 7,431 shares during the last quarter. USS Investment Management Ltd increased its stake in Cardinal Health by 13.8% in the fourth quarter. USS Investment Management Ltd now owns 89,751 shares of the company’s stock valued at $6,899,000 after acquiring an additional 10,900 shares during the last quarter. Kentucky Retirement Systems Insurance Trust Fund purchased a new stake in Cardinal Health during the first quarter valued at about $692,000. Aviva PLC lifted its stake in Cardinal Health by 23.3% during the fourth quarter. Aviva PLC now owns 261,843 shares of the company’s stock worth $8,670,000 after purchasing an additional 49,496 shares during the last quarter. Finally, LSV Asset Management boosted its holdings in shares of Cardinal Health by 0.3% in the 1st quarter. LSV Asset Management now owns 2,456,552 shares of the company’s stock worth $185,470,000 after purchasing an additional 7,000 shares in the last quarter. 86.01% of the stock is currently owned by hedge funds and other institutional investors.

Cardinal Health Stock Performance

NYSE:CAH opened at $88.17 on Tuesday. The firm has a 50-day simple moving average of $90.31 and a 200-day simple moving average of $85.09. Cardinal Health, Inc. has a one year low of $64.99 and a one year high of $95.45. The firm has a market cap of $22.10 billion, a P/E ratio of 89.06, a P/E/G ratio of 0.92 and a beta of 0.79.

Cardinal Health (NYSE:CAH) last announced its earnings results on Tuesday, August 15th. The company reported $1.55 EPS for the quarter, topping analysts’ consensus estimates of $1.49 by $0.06. The business had revenue of $53.45 billion during the quarter, compared to the consensus estimate of $52.72 billion. Cardinal Health had a net margin of 0.13% and a negative return on equity of 67.01%. The firm’s revenue was up 13.5% on a year-over-year basis. During the same period in the previous year, the company posted $1.05 earnings per share. On average, research analysts predict that Cardinal Health, Inc. will post 6.65 EPS for the current fiscal year.

Cardinal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Sunday, October 15th. Investors of record on Tuesday, October 3rd will be issued a dividend of $0.5006 per share. This represents a $2.00 annualized dividend and a yield of 2.27%. The ex-dividend date of this dividend is Monday, October 2nd. Cardinal Health’s dividend payout ratio (DPR) is 202.02%.

Insider Buying and Selling at Cardinal Health

In other news, insider Jessica L. Mayer sold 30,145 shares of Cardinal Health stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $90.84, for a total transaction of $2,738,371.80. Following the completion of the transaction, the insider now directly owns 95,533 shares of the company’s stock, valued at approximately $8,678,217.72. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other news, CEO Deborah Weitzman sold 6,712 shares of the company’s stock in a transaction that occurred on Monday, August 28th. The stock was sold at an average price of $89.81, for a total transaction of $602,804.72. Following the completion of the transaction, the chief executive officer now directly owns 44,202 shares of the company’s stock, valued at approximately $3,969,781.62. The sale was disclosed in a filing with the SEC, which is available at this link. Also, insider Jessica L. Mayer sold 30,145 shares of the company’s stock in a transaction on Wednesday, August 16th. The stock was sold at an average price of $90.84, for a total transaction of $2,738,371.80. Following the transaction, the insider now owns 95,533 shares of the company’s stock, valued at $8,678,217.72. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 95,052 shares of company stock valued at $8,401,034. 0.17% of the stock is owned by company insiders.

Analyst Ratings Changes

Several analysts have issued reports on CAH shares. UBS Group upped their target price on Cardinal Health from $93.00 to $97.00 in a research note on Sunday, June 11th. Robert W. Baird boosted their price target on shares of Cardinal Health from $107.00 to $108.00 and gave the stock an “outperform” rating in a research note on Wednesday, August 16th. Mizuho raised their price objective on Cardinal Health from $94.00 to $96.00 and gave the company a “neutral” rating in a research note on Wednesday, August 16th. Credit Suisse Group boosted their target price on Cardinal Health from $90.00 to $100.00 in a research note on Monday, June 12th. Finally, Evercore ISI raised their price target on Cardinal Health from $90.00 to $95.00 in a research report on Friday, June 9th. Eight investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $94.69.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.